Pramiracetam is an organonitrogen compound and an organooxygen compound. It derives from an alpha-amino acid.

Pramiracetam has been previously approved in some eastern European countries under the brand names Pramistar, Neupramir, and Remen. It was also previously approved in the United States with orphan drug designation. Pramiracetam has been studied for the use in Alzheimer's disease and as an adjunct treatment to restore cognitive functioning post-electroconvulsive therapy in severe depression.

You can contact me if you need anything.Content, color and packaging can be customized.And of course the higher the quantity demanded the lower the price.

Any question ,please do not hesitate to tell me ! Waiting hearing from you!